NovoLog® Mix 70/30. One insulin that works in two different ways.
NovoLog® Mix 70/30 is a man-made insulin that is used to control high blood
sugar in adults with diabetes mellitus.
Along with a healthy diet and exercise, NovoLog® Mix 70/30 FlexPen® helps
you manage your diabetes.
- NovoLog® Mix 70/30 is one insulin that covers both mealtime and in-between mealtime
blood sugar levels
- In a study, people who took NovoLog® Mix 70/30 had better mealtime coverage
and fewer severe low blood sugar episodes than people taking another premix 70/30
insulin
- Once in use, NovoLog® Mix 70/30 FlexPen® must be kept at room temperature below
86ºF for up to 14 days
- NovoLog® Mix 70/30 FlexPen® can be used with NovoTwist® 30G (8mm) and
32G Tip (5mm) needles, our thinnest needles†
What to know about risks and side effects:
First, make sure you read the Important Safety Information below. It's a good way to
learn more about how to take NovoLog® Mix 70/30 and any possible side effects
to watch out for.
Here are a few key things to keep in mind:
- You shouldn't take NovoLog® Mix 70/30 if your blood sugar is too low (hypoglycemia)
or if you are allergic to anything in it
- You should eat within 15 minutes after using NovoLog® Mix 70/30 to avoid low
blood sugar
- Always talk to your doctor before changing the type of insulin you use
- Never mix NovoLog® Mix 70/30 with other insulin products or use it in an insulin
pump
- Make sure your doctor knows about any other medicines you're taking and any other
medical conditions you have
Remember, NovoLog® Mix 70/30 may be a good option for you, but only your doctor
can make that decision. So talk to your doctor about how NovoLog® Mix 70/30
FlexPen® might fit into your diabetes management plan, along with diet and exercise.
Additional Important Safety Information
One study of people with type 1 and type 2 diabetes found that NovoLog® Mix
70/30 did a better job of reducing blood glucose levels after meals than did human
premix 70/30 insulin. A1C and fasting blood glucose levels were similar in both
groups. The importance of differences in high postprandial (after-meal) glucose
levels between the groups studied as it relates to long-term complications of diabetes
has not been established.
Dosing of NovoLog® Mix 70/30 will differ among patients and should be set by
the healthcare professional familiar with the patient's energy needs, eating habits,
and other lifestyle factors. As with all insulins, the length of action may vary
according to the dose, injection site, blood flow, temperature, and level of physical
activity and conditioning.
*Once in use, NovoLog® Mix 70/30 FlexPen® must be kept at room temperature below 86ºF
for up to 14 days.
†Needles are sold separately and may require a prescription in some states.
Needles and FlexPen® must not be shared.